具有降低表面电荷的瘤治疗性HAdV-5结合了降低毒性和改善瘤向性
Frederik Wienen1, Robin Nilson1, Ellen Allmendinger1
1Department of Gene Therapy, Ulm University, 89081 Ulm, Germany.
Molecular therapy. Oncology
|January 6, 2025
概括
修改后的人类腺病毒5型 (HAdV-5) 型病毒显示改善瘤向性和减少肝毒性. 这种新的HAdV-5-HexPos3_ΔCAR载体增强了抗癌疗法的疗效,并具有更好的安全性.
科学领域:
- 瘤治疗性病毒疗法
- 基因疗法载体 基因疗法载体
- 癌症研究 癌症研究
背景情况:
- 基于5型人类腺病毒 (HAdV-5) 的菌性病毒是有前途的癌症治疗方法.
- 系统管理面临诸多挑战,包括瘤向不良,非位器官转导,以及由于HAdV-5热流症导致的严重肝毒性.
研究的目的:
- 设计一种基于HAdV-5的新性瘤载体,增强瘤向性和降低全身毒性.
- 评估改性载体的*体外*和*体内*性能,重点关注热带性,瘤与肝脏的比率和安全性.
主要方法:
- 对HAdV-5六子蛋白进行基因改造,以减少负表面电荷,从而产生HAdV-5-HexPos3.
- 在修改的载体 (HAdV-5-HexPos3_ΔCAR) 中,Coxsackie和腺病毒受体 (CAR) 结合的切除.
- 在癌症细胞系中的体外转导测定和在瘤携带NSG小鼠中的体内研究,使用静脉注射.
主要成果:
- HAdV-5-HexPos3_ΔCAR证明了CAR独立的,增强的癌细胞转导 *在体外*.
- 静脉注射给小鼠显示,与对照组相比,非位器官热带性显著降低,瘤与肝脏载体负荷比率提高了29倍.
- 一种有条件复制的HAdV-5-HexPos3_ΔCAR载体被很好地容忍,与引起严重肝毒性的对照载体不同.
结论:
- HAdV-5-HexPos3_ΔCAR载体平台为开发基于HAdV-5的更安全,更有效的菌病毒提供了一个有前途的战略.
- 减少全身毒性和改善内载体积累是增强抗癌疗法的关键优势.
相关概念视频
01:27Tumor Immunotherapy
394
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
394
02:49Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
01:30Cancer Vaccines
237
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
237
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K